Use of Programs Sample Clauses

Use of Programs. Except for the licenses and other rights granted by DCI to RMST and Ellipse as set forth in this Agreement or as otherwise specified in this Agreement, DCI will have the sole and exclusive right to exhibit, license, promote, distribute, sell and otherwise use the Programs and the Program Elements and to exploit all rights therein in any and all manner in all markets and in all media now in existence or to be developed hereafter throughout the world in perpetuity without any additional payment whatsoever to any individual or entity.
Sample 1
AutoNDA by SimpleDocs
Use of Programs. 19. List all delivery companies and services that the landlord will make available to the tenant. All benefits or services that are not listed are the tenant's responsibility. XIII.
Sample 1
Use of Programs. This Agreement is not intended to transfer either Party’s Intellectual Property Rights except as expressly provided herein. Zivian Health may license use of and access to Programs to APC as further described in the APC Enrollment Forms. Zivian Health retains all other Intellectual Property Rights in the Programs. APC shall not do or attempt to do, any of the following: reverse-engineer, decompile, disassemble, translate, create derivative works from, or otherwise attempt to obtain access to the source code of, any aspect of the Programs. APC shall not copy, reproduce, alter, or otherwise modify the Programs. APC shall not lease, loan, sublicense, distribute, or otherwise provide others access to any aspect of the Programs, except as expressly permitted in this Agreement.
Sample 1
Use of Programs. The Customer may use the Programs at the licensed site or in a remote access mode solely to process its own data and the data of all Customer remote sites located within the Customer's jurisdiction. The Customer shall ensure that any remote site that has access to the Programs complies with this agreement. The Customer shall be liable for any breach of this agreement by any remote site or any third party. The Customer may transfer the Programs to any other site owned by Customer upon written notice to JSI. The Customer shall not assign, sublicense, extend or transfer its rights under this Agreement by operation of law or otherwise. The Customer shall have sole responsibility for the propriety, confidentiality, and the use of the data maintained by the Programs. Except to the extent caused by JSI's negligence, the Customer shall hold JSI, its licensor, its agents, employees and representatives harmless from and against any and all expense, liability, loss, claim or damage to all persons and property arising out of the Customer's possession, operation and use of the Programs.
Sample 1
Use of Programs. Protrainy reserves the right to cancel or reschedule any Program (online/offline/short term/long term) or live lectures/webinars, or to alter, modify or rearrange the schedule of topics, as well as the point value or weight of assignments, tests, quizzes, exams, projects and other such evaluations of progress. You also understand that Protrainy, at its sole discretion, may limit, suspend, or terminate your use of the Platform or Programs and/or all Protrainy-provided services related to the Programs, such as access to Protrainy coaches or support services, evaluation services, or certifications. You also understand that Protrainy may modify or discontinue all services related to its Programs at its sole discretion. You agree that Protrainy shall not be liable to you or to any third party for any such modification, suspension or discontinuance. Nothing in these Terms shall be construed to obligate Protrainy to maintain and support the Platform or Programs or any part or portion thereof or any associated services. You agree that Protrainy shall be under no liability whatsoever to you in the event of non-availability of the Platform or any portion thereof occasioned by Act of God, war, disease, revolution, epidemic, riot, civil commotion, strike, lockout, flood, fire, satellite failure, failure of any public utility, man-made disaster or any other cause whatsoever beyond the control of Protrainy. Participants of Protrainy online live lectures and webinars shall be provided access to such classes via email. You agree not to share such access with any third party. If you are unable to attend an online live lecture/webinar, please provide Protrainy with prior intimation regarding this. You shall be exclusively responsible for obtaining and maintaining any equipment or ancillary services needed to connect to, access, receive or use the Platform, including, without limitation, hardware devices, software, and other internet, wireless, broadband, phone and/or other mobile communication device connection services. You shall be exclusively responsible for ensuring that such equipment or ancillary services are compatible with the Platform, and you shall be responsible for all charges incurred in connection with the use of the Platform and Program in connection with all such equipment and ancillary services. Usage of softwares is onus of users and Protrainy shall not be responsible for the same.
Sample 1
Use of Programs. Licensee may only make the Programs available to customers as a nominee in the CFFAs, and may be distributed, including without limitation, on a free advertising supported basis, on basic cable, on a subscription basis, via TV everywhere, as part of a linear programming channel with or without accompanying VOD.
Sample 1
Use of Programs. 1.1 You may install and use the Programs and accompanying docu- mentation internally in your organization solely for evaluation, testing, disaster recovery and version update purposes on a single computer sys- tem. You may not use the Programs for any development, commercial or production purpose. The Programs may not be transferred, sold, assigned, sublicensed or otherwise conveyed, whether by operation of law or otherwise, to another party without Nobix' prior written consent.
Sample 1
AutoNDA by SimpleDocs

Related to Use of Programs

  • Use of Project Issuer does hereby covenant and agree that it will not take any action during the term of this Agreement, other than pursuant to Article IX of this Agreement or Article IX of the Indenture, to interfere with Company's ownership of the Project or to prevent Company from having possession, custody, use and enjoyment of the Project.

  • Use of websites (a) The Company may satisfy its obligation under this Agreement to deliver any information in relation to those Lenders (the “Website Lenders”) who accept this method of communication by posting this information onto an electronic website designated by the Company and the Agent (the “Designated Website”) if:

  • Use of Property The Property as defined herein shall be for the sole and exclusive use and occupation by the Tenant(s) and same’s exclusive family namely:

  • Use of Pronouns All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the person or persons referred to may require.

  • Use of Names The Manager and the Fund agree that the Manager has a proprietary interest in the names “DFA” and “Dimensional,” and that the Fund and/or Portfolio may use such names only as permitted by the Manager, and the Fund further agrees to cease use of such names promptly after receipt of a written request to do so from the Manager.

  • Publicity/Use of Names Neither Party shall use the name, trademark, trade name or logo of the other Party, its Affiliates or their respective employee(s) in any publicity, promotion, news release or disclosure relating to this Agreement or its subject matter, without the prior express written permission of the other Party, except for those disclosures expressly authorized under this Article 4. Following execution of this Agreement, either Party may issue a press release announcing the existence of this Agreement in form and substance agreed to in writing by both Parties, such agreement to not be unreasonably withheld or delayed. Each Party agrees not to issue any other press release or other public statement disclosing other information relating to this Agreement or the transactions contemplated hereby without the prior written consent of the other Party, which consent shall not be unreasonably withheld or delayed; provided that Arvinas agrees that it shall be deemed reasonable for Pfizer to withhold its consent for the disclosure of any information related to a Target or a specific Compound or the amount of any payment made or to be made under this Agreement; and provided further that any disclosure which is required by Law or the rules of a securities exchange, as reasonably advised by the disclosing Party’s counsel, may be made subject to the following. Each Party agrees to provide to the other Party a copy of any public announcement regarding this Agreement or the subject matter thereof as soon as reasonably practicable under the circumstances prior to its scheduled release. Except under extraordinary circumstances or to the extent any such advance notice or notice period is not consistent with applicable Law, each Party shall provide the other with an advance copy of any such announcement at least [**] prior to its scheduled release. Each Party shall have the right to expeditiously review and recommend changes to any such announcement and, except as otherwise required by Law, the Party whose announcement has been reviewed shall remove any information the reviewing Party reasonably deems to be inappropriate for disclosure. The contents of any announcement or similar publicity which has been reviewed and approved by the reviewing Party can be re-released by either Party without a requirement for re-approval. In addition, except to the extent required by Laws in connection with patent enforcement activities conducted in accordance with Article 7, Pfizer shall not use the name “Yale” or “Yale University,” nor any variation or adaptation thereof, nor any trademark, trade name or other designation owned by Yale University, nor the names of any of its trustees, officers, faculty, students, employees or agents, for any purpose without the prior written consent of Yale University in each instance, such consent to be granted or withheld by Yale University in its sole discretion, except that Pfizer may state that it has sublicensed from Yale University one or more of the patents or applications comprising the Yale Licensed Patents.

  • Use of Proceeds The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in the Prospectus under “Use of Proceeds.”

Time is Money Join Law Insider Premium to draft better contracts faster.